V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003205 | 10002045 | 1.78 | 84.5 | null | 2017-03-17 | 2017-03-19 | Hydroxycarbamide | N | null | 10465359 | HYDROXYCARBAMIDE |
| 10003206 | 10002045 | 1.7 | 61.7 | Adjuvant (A) | 2016-02-08 | 2016-02-15 | Cisplatin + Vinorelbine (IV) | 2 | N | 10465359 | CISPLATIN + VINORELBINE |
| 10003207 | 10002046 | null | 54 | Adjuvant (A) | 2017-06-07 | 2017-06-22 | Cisplatin + Vinorelbine (PO) | N | N | 10465554 | CISPLATIN + VINORELBINE |
| 10003208 | 10006371 | 0 | null | Adjuvant (A) | 2016-07-22 | 2016-07-29 | Carboplatin + Vinorelbine IV &PO D8 | 2 | N | 10465623 | CARBOPLATIN + VINORELBINE |
| 10003209 | 10006371 | 1.68 | 0 | Disease modification (D) | 2017-09-24 | 2017-09-26 | Rituximab | 2 | N | 10465623 | RITUXIMAB |
| 10003210 | 10002047 | 1.56 | 73.1 | Palliative (P) | 2018-11-09 | 2018-11-15 | PEMBROLIZUMAB | 02 | Y | 10465688 | PEMBROLIZUMAB |
| 10003211 | 10002047 | 1.84 | 80 | Disease modification (D) | 2018-11-19 | 2018-11-20 | Rituximab | 02 | N | 10465688 | RITUXIMAB |
| 10003212 | 10002048 | 1.8 | 89.7 | Palliative (P) | 2014-04-12 | 2014-05-14 | CVP R | 02 | N | 10465732 | CVP R |
| 10003213 | 10002048 | 1.78 | 103.1 | Palliative (P) | 2018-11-28 | 2018-12-09 | PEMBROLIZUMAB | 02 | N | 10465732 | PEMBROLIZUMAB |
| 10003214 | 10002049 | 1.77 | 69.5 | Disease modification (D) | 2018-07-17 | 2018-07-17 | Hydroxycarbamide | N | N | 10465762 | HYDROXYCARBAMIDE |
| 10003215 | 10006374 | 1.74 | 78 | Disease modification (D) | 2018-05-30 | 2018-07-03 | R GCVP | N | N | 10465791 | CVP R |
| 10003216 | 10006374 | 1.57 | 54 | Palliative (P) | 2018-04-27 | 2018-05-03 | CARBOPLATIN + VINORELBINE | N | null | 10465791 | CARBOPLATIN + VINORELBINE |
| 10003217 | 10002050 | 1.68 | 92.6 | Palliative (P) | 2014-04-06 | 2014-04-17 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 10465841 | GEMCITABINE |
| 10003218 | 10002051 | 1.51 | 58.2 | Palliative (P) | 2016-03-04 | 2016-03-10 | EOX | N | N | 10465854 | EOX |
| 10003219 | 10006375 | null | 62.5 | null | 2017-11-21 | 2017-12-07 | CARBOPLATIN + VINORELBINE | N | N | 10465962 | CARBOPLATIN + VINORELBINE |
| 10003220 | 10002052 | 1.82 | 70.6 | Curative (C) | 2016-02-24 | 2016-03-09 | CVP R | 02 | N | 10466008 | CVP R |
| 10003221 | 10002053 | 1.68 | 78 | Palliative (P) | 2019-02-18 | 2019-02-21 | Trial Unspecified | Y | N | 10466022 | TRIAL |
| 10003222 | 10002054 | 1.53 | 45.1 | Palliative (P) | 2016-12-13 | 2016-12-23 | R GCVP | 02 | N | 10466114 | CVP R |
| 10003223 | 10002055 | 1.63 | 68 | null | 2017-07-26 | 2017-07-26 | Trial Unspecified | N | null | 10466143 | TRIAL |
| 10003224 | 10002055 | 1.76 | 86.6 | null | 2019-01-05 | 2019-01-05 | Trial Unspecified | 01 | N | 10466143 | TRIAL |
| 10003225 | 10002056 | null | 89.5 | Curative (C) | 2017-07-21 | 2017-08-13 | CVP R | N | N | 10466169 | CVP R |
| 10003226 | 10002057 | 1.7 | null | Disease modification (D) | 2017-10-26 | 2017-11-03 | Rituximab | N | Y | 10466273 | RITUXIMAB |
| 10003227 | 10002057 | 1.54 | 45 | null | 2018-08-29 | 2018-09-03 | Rituximab | 02 | N | 10466273 | RITUXIMAB |
| 10003228 | 10002058 | 0 | 53 | null | 2017-07-14 | 2017-07-29 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 10466360 | GEMCITABINE |
| 10003229 | 10002059 | null | 59 | Palliative (P) | null | 2015-03-08 | GEMCITABINE | N | N | 10466384 | GEMCITABINE |
| 10003230 | 10002060 | 1.73 | null | Palliative (P) | 2017-03-16 | 2017-03-22 | Trial Unspecified | Y | N | 10466409 | TRIAL |
| 10003231 | 10002061 | 1.81 | 104.6 | Palliative (P) | 2017-07-16 | 2017-07-28 | PEMBROLIZUMAB | 2 | N | 10466470 | PEMBROLIZUMAB |
| 10003232 | 10006378 | 1.6 | 69 | Palliative (P) | 2017-05-13 | 2017-05-17 | Cisplatin + Pemetrexed | N | N | 10466471 | CISPLATIN + PEMETREXED |
| 10003233 | 10002062 | 1.7 | 63.9 | Palliative (P) | 2018-06-09 | 2018-06-29 | Rituximab | N | N | 10466478 | RITUXIMAB |
| 10003234 | 10002063 | 1.7 | 88.1 | Palliative (P) | 2015-11-02 | 2015-11-17 | PEMBROLIZUMAB | 02 | N | 10466530 | PEMBROLIZUMAB |
| 10003235 | 10002064 | 1.72 | 66.2 | Adjuvant (A) | 2016-07-29 | 2016-08-21 | ECX | N | N | 10466552 | ECX |
| 10003236 | 10002065 | 1.75 | 104.6 | Palliative (P) | 2016-12-08 | 2016-12-10 | R GCVP | N | N | 10466616 | CVP R |
| 10003237 | 10002066 | 0 | 72.6 | Adjuvant (A) | 2018-06-05 | 2018-06-05 | CISPLATIN + VINORELBINE | 2 | N | 10466668 | CISPLATIN + VINORELBINE |
| 10003238 | 10006379 | 1.65 | 123 | Disease modification (D) | 2018-04-11 | 2018-04-11 | Hydroxycarbamide | 2 | N | 10466670 | HYDROXYCARBAMIDE |
| 10003239 | 10002067 | null | 52 | Not known (9) | 2016-04-08 | 2016-04-19 | Trial Unspecified | N | N | 10466680 | TRIAL |
| 10003240 | 10002067 | 1.79 | 84.2 | Disease modification (D) | null | 2016-11-13 | Hydroxycarbamide | 2 | N | 10466680 | HYDROXYCARBAMIDE |
| 10003241 | 10002067 | 1.67 | 66.4 | Adjuvant (A) | 2016-03-27 | 2016-04-05 | Cisplatin + Vinorelbine (PO) | 2 | N | 10466680 | CISPLATIN + VINORELBINE |
| 10003242 | 10002068 | 1.54 | 65 | Palliative (P) | 2018-03-06 | 2018-03-09 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 10466925 | GEMCITABINE |
| 10003243 | 10006381 | 1.74 | 73 | Palliative (P) | 2018-03-20 | 2018-03-31 | ECX | N | Y | 10466991 | ECX |
| 10003244 | 10002069 | 1.64 | 59.4 | Palliative (P) | 2017-03-04 | 2017-03-07 | ECX | 02 | N | 10467020 | ECX |
| 10003245 | 10002070 | null | 0 | Palliative (P) | 2016-12-21 | 2016-12-29 | PEMBROLIZUMAB | N | N | 10467057 | PEMBROLIZUMAB |
| 10003246 | 10002071 | 1.57 | 82.5 | Disease modification (D) | 2016-01-08 | 2016-01-10 | Rituximab | N | N | 10467100 | RITUXIMAB |
| 10003247 | 10002072 | 1.78 | 81.2 | Disease modification (D) | null | 2016-09-28 | Hydroxycarbamide | N | N | 10467165 | HYDROXYCARBAMIDE |
| 10003248 | 10002073 | 1.67 | 71.2 | Palliative (P) | 2017-10-03 | 2017-10-08 | CISPLATIN + VINORELBINE | N | N | 10467204 | CISPLATIN + VINORELBINE |
| 10003249 | 10002074 | 1.78 | 80.8 | Disease modification (D) | 2014-01-01 | 2014-01-05 | Hydroxycarbamide | N | N | 10467212 | HYDROXYCARBAMIDE |
| 10003250 | 10002075 | 0 | null | Palliative (P) | 2018-12-19 | 2018-12-26 | PEMBROLIZUMAB | 2 | N | 10467213 | PEMBROLIZUMAB |
| 10003251 | 10002076 | 1.73 | 0 | Palliative (P) | 2015-04-25 | 2015-04-25 | Carboplatin + Vinorelbine Oral | 02 | N | 10467261 | CARBOPLATIN + VINORELBINE |
| 10003252 | 10006382 | 1.8 | 55.6 | Palliative (P) | 2014-01-18 | 2014-01-19 | CARBOPLATIN + VINORELBINE | 2 | N | 10467268 | CARBOPLATIN + VINORELBINE |
| 10003253 | 10002077 | null | null | Palliative (P) | 2014-08-18 | 2014-08-28 | PEMBROLIZUMAB | N | N | 10467273 | PEMBROLIZUMAB |
| 10003254 | 10006383 | 1.8 | 86.35 | Palliative (P) | 2018-11-16 | 2018-11-16 | Enzalutamide | 02 | N | 10467279 | ENZALUTAMIDE |